Suppr
超能文献

Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases.

作者信息

Sharp Dan, Ringer Sara, Park K T, Tole Swati, Rubin David T, Regueiro Miguel

机构信息

IBD patient advocate, DanSharpIBD.org.

IBD patient advocate, InflamedAndUntamed.org.

出版信息

Crohns Colitis 360. 2020 Mar 20;2(1):otaa011. doi: 10.1093/crocol/otaa011. eCollection 2020 Jan.

DOI:10.1093/crocol/otaa011

PMID:36777962

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9802181/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b2/9802181/966628a7ba6a/otaa011f0001.jpg

相似文献

Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases.

Crohns Colitis 360. 2020 Mar 20;2(1):otaa011. doi: 10.1093/crocol/otaa011. eCollection 2020 Jan.

Music interventions for mechanically ventilated patients.

Cochrane Database Syst Rev. 2014;2014(12):CD006902. doi: 10.1002/14651858.CD006902.pub3. Epub 2014 Dec 9.

Hypothalamic digoxin, hemispheric chemical dominance, and inflammatory bowel disease.

Int J Neurosci. 2003 Sep;113(9):1221-40. doi: 10.1080/00207450390232328.

Current issues in the design of clinical trials in IBD.

Nestle Nutr Inst Workshop Ser. 2014;79:19-28. doi: 10.1159/000360670. Epub 2014 Sep 5.

Evolution of Clinical Trials in Inflammatory Bowel Diseases.

Curr Gastroenterol Rep. 2018 Aug 4;20(9):41. doi: 10.1007/s11894-018-0648-3.

Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.

Lancet Gastroenterol Hepatol. 2022 Mar;7(3):254-261. doi: 10.1016/S2468-1253(21)00297-1. Epub 2022 Jan 17.

Improving quality of care in inflammatory bowel disease: what changes can be made today?

J Crohns Colitis. 2014 Sep;8(9):919-26. doi: 10.1016/j.crohns.2014.02.022. Epub 2014 Apr 6.

Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions.

Aliment Pharmacol Ther. 2022 Mar;55(6):658-669. doi: 10.1111/apt.16781. Epub 2022 Feb 7.

Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease.

J Med Internet Res. 2016 Jun 3;18(6):e124. doi: 10.2196/jmir.5655.

Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments.

Gut. 2021 Feb;70(2):418-426. doi: 10.1136/gutjnl-2020-320690. Epub 2020 Jul 22.

引用本文的文献

Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis.

United European Gastroenterol J. 2025 May;13(4):542-551. doi: 10.1002/ueg2.12731. Epub 2024 Dec 19.

Leveraging Virtual Technology to Conduct Clinical Trials in Inflammatory Bowel Disease.

Gastroenterol Hepatol (N Y). 2023 Aug;19(8):468-474.

Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease.

J Crohns Colitis. 2023 Nov 24;17(11):1882-1891. doi: 10.1093/ecco-jcc/jjad090.

Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis.

Crohns Colitis 360. 2021 Dec 9;3(4):otab079. doi: 10.1093/crocol/otab079. eCollection 2021 Oct.

本文引用的文献

Competition for Clinical Trials in Inflammatory Bowel Diseases.

Gastroenterology. 2019 Dec;157(6):1457-1461.e2. doi: 10.1053/j.gastro.2019.08.020. Epub 2019 Aug 21.

Informed Consent in IBD Trials: Where We Are and Where We Need to Go.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1115-1119. doi: 10.1093/ibd/izz067.

Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review.

Autoimmun Rev. 2019 May;18(5):439-454. doi: 10.1016/j.autrev.2019.03.002. Epub 2019 Mar 4.

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus.

Dig Dis. 2019;37(4):266-283. doi: 10.1159/000496739. Epub 2019 Feb 6.

Evolution of Clinical Trials in Inflammatory Bowel Diseases.

Curr Gastroenterol Rep. 2018 Aug 4;20(9):41. doi: 10.1007/s11894-018-0648-3.

Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):370-379. doi: 10.1016/j.cgh.2018.07.013. Epub 2018 Jul 18.

Precision Medicine in Hormone Receptor-Positive Breast Cancer.

Front Oncol. 2018 May 4;8:144. doi: 10.3389/fonc.2018.00144. eCollection 2018.

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review.

Clin Gastroenterol Hepatol. 2018 Sep;16(9):1407-1419.e22. doi: 10.1016/j.cgh.2018.02.051. Epub 2018 Mar 27.

Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set.

Clin Gastroenterol Hepatol. 2018 May;16(5):637-647.e13. doi: 10.1016/j.cgh.2017.08.025. Epub 2017 Aug 24.

Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.

BMJ Open. 2017 Jun 9;7(6):e016146. doi: 10.1136/bmjopen-2017-016146.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译